This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Arromax Pharmatech Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Jingbing Wang: Innovator in Pharmaceutical Chemistry
Introduction
Jingbing Wang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds with potential therapeutic applications.
Latest Patents
Wang holds a patent for a diphenylaminopyrimidine and triazine compound, which is detailed in his patent titled "Diphenylaminopyrimidine and triazine compound, and pharmaceutical composition and use thereof." This compound, represented by a specific formula, exhibits pharmacodynamic and pharmacokinetic properties, along with ALK kinase inhibitory activity. The patent highlights the versatility of the compound, which can exist in various forms, including pharmaceutically acceptable salts and stereoisomers.
Career Highlights
Wang is associated with Arromax Pharmatech Co., Ltd., where he continues to advance his research and development efforts. His work focuses on creating innovative pharmaceutical solutions that address critical health challenges.
Collaborations
Wang collaborates with esteemed colleagues, including Xiaoyong Le and Jian Hong, to enhance the scope and impact of his research. Their combined expertise contributes to the development of groundbreaking pharmaceutical compounds.
Conclusion
Jingbing Wang's contributions to pharmaceutical chemistry through his innovative patents and collaborations underscore his role as a leading inventor in the field. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile